Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Biotech Industry Analysis

UpdatedAug 10, 2025
DataAggregated Company Financials
Companies22
  • 7D-1.0%
  • 3M16.3%
  • 1Y1.6%
  • YTD10.8%

Over the last 7 days, the Biotech industry has dropped 1.0%, driven by a pullback from Oxford Biomedica of 5.2%. As for the longer term, the industry's performance has been flat for the past year. Earnings are forecast to grow by 36% annually.

Industry Valuation and Performance

Has the U.K. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 10 Aug 2025UK£3.1bUK£854.6m-UK£103,198,438.5012.1x-29.8x3.6x
Tue, 08 Jul 2025UK£2.6bUK£854.3m-UK£103,607,042.2412.9x-25.4x3.1x
Thu, 05 Jun 2025UK£2.6bUK£879.7m-UK£100,590,131.0013.8x-25.8x2.9x
Sat, 03 May 2025UK£2.4bUK£879.3m-UK£68,213,282.3812.8x-35x2.7x
Mon, 31 Mar 2025UK£2.4bUK£845.6m-UK£276,957,839.0717.7x-8.6x2.8x
Wed, 26 Feb 2025UK£2.5bUK£841.6m-UK£293,960,127.6983.8x-8.7x3x
Fri, 24 Jan 2025UK£2.7bUK£842.3m-UK£296,248,332.7881.9x-8.9x3.1x
Sun, 22 Dec 2024UK£2.5bUK£847.4m-UK£303,686,383.2173.7x-8.3x3x
Tue, 19 Nov 2024UK£2.6bUK£841.1m-UK£294,635,028.9282.2x-9x3.2x
Thu, 17 Oct 2024UK£3.0bUK£840.4m-UK£296,030,409.4597.4x-10x3.5x
Sat, 14 Sep 2024UK£2.9bUK£832.3m-UK£311,351,926.9993.8x-9.4x3.5x
Mon, 12 Aug 2024UK£2.6bUK£838.2m-UK£257,848,172.0830.2x-10.2x3.1x
Wed, 10 Jul 2024UK£2.6bUK£835.6m-UK£260,651,352.7329.5x-10x3.1x
Fri, 07 Jun 2024UK£2.8bUK£836.6m-UK£278,820,783.7330.7x-10x3.3x
Sun, 05 May 2024UK£3.0bUK£836.4m-UK£299,361,404.7631.4x-10x3.6x
Tue, 02 Apr 2024UK£3.1bUK£903.1m-UK£202,231,612.6028.6x-15.2x3.4x
Thu, 29 Feb 2024UK£3.1bUK£896.7m-UK£197,735,821.6532.2x-15.7x3.5x
Sat, 27 Jan 2024UK£6.4bUK£1.3b-UK£245,297,001.0038.7x-26.3x5.1x
Mon, 25 Dec 2023UK£6.3bUK£1.3b-UK£245,293,031.0038x-25.7x5x
Wed, 22 Nov 2023UK£6.3bUK£1.3b-UK£246,203,740.0037x-25.5x4.9x
Fri, 20 Oct 2023UK£6.5bUK£1.3b-UK£251,291,476.0038.9x-25.9x5.1x
Sun, 17 Sep 2023UK£6.6bUK£1.3b-UK£207,474,745.0023.1x-31.8x5.1x
Tue, 15 Aug 2023UK£6.7bUK£1.3b-UK£208,073,368.0023.6x-32.3x5.3x
Thu, 13 Jul 2023UK£6.8bUK£1.3b-UK£207,842,888.0023.9x-32.7x5.4x
Sat, 10 Jun 2023UK£7.0bUK£1.3b-UK£205,984,263.0023x-33.9x5.5x
Mon, 08 May 2023UK£7.1bUK£1.3b-UK£204,849,398.0023.6x-34.8x5.7x
Wed, 05 Apr 2023UK£7.1bUK£1.2b-UK£153,893,955.0024.2x-46.3x5.7x
Fri, 03 Mar 2023UK£7.5bUK£1.2b-UK£156,982,074.0026.5x-47.7x6x
Sun, 29 Jan 2023UK£7.4bUK£1.2b-UK£146,354,130.0026.8x-50.8x6.4x
Tue, 27 Dec 2022UK£7.5bUK£1.2b-UK£138,546,305.0026.9x-53.9x6.4x
Thu, 24 Nov 2022UK£7.7bUK£1.2b-UK£139,325,124.0024.4x-55.1x6.6x
Sat, 22 Oct 2022UK£6.9bUK£1.2b-UK£150,705,336.0026x-45.9x6x
Mon, 19 Sep 2022UK£7.7bUK£1.2b-UK£179,626,949.0026x-43.1x6.7x
Wed, 17 Aug 2022UK£7.5bUK£1.1b-UK£200,965,234.0037.5x-37.5x6.8x
Price to Earnings Ratio

-37.5x


Total Market Cap: UK£7.5bTotal Earnings: -UK£200,965,234.00Total Revenue: UK£1.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Biotech Industry Price to Earnings3Y Average -30x202320242025
Current Industry PE
  • Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 4.9x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 8.5% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market3.24%
Healthcare-0.94%
Biotech-1.03%
Biotech-1.03%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GNS GenusUK£25.201.2%
+UK£19.7m		44.3%PS2.5x
FARN Faron Pharmaceuticals OyUK£2.109.1%
+UK£19.6m		15.1%PE-10.5x
SCLP Scancell HoldingsUK£0.117.3%
+UK£7.8m		-38.9%PE-7.2x
APTA Aptamer GroupUK£0.005656.9%
+UK£5.5m		126.0%PS12.4x
AREC Arecor TherapeuticsUK£0.6411.4%
+UK£2.5m		-30.6%PS4.7x

Latest News

BVXP
UK£24.25
Bioventix
7D
-9.0%
1Y
-44.3%
APTA
UK£0.0056
Aptamer Group
7D
56.9%
1Y
126.0%
TRX
UK£0.31
Tissue Regenix Group
7D
-8.8%
1Y
-50.8%
AVCT
UK£0.46
Avacta Group
7D
-2.1%
1Y
-33.1%
OXB
UK£4.41
Oxford Biomedica
7D
-5.2%
1Y
25.5%

Oxford Biomedica plc's (LON:OXB) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Jul 29
Oxford Biomedica plc's (LON:OXB) Price Is Right But Growth Is Lacking After Shares Rocket 30%
GNS
UK£25.20
Genus
7D
1.2%
1Y
44.3%

There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Jul 25
There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise
SCLP
UK£0.11
Scancell Holdings
7D
7.3%
1Y
-38.9%
AREC
UK£0.64
Arecor Therapeutics
7D
11.4%
1Y
-30.6%
PRTC
UK£1.33
PureTech Health
7D
-3.5%
1Y
-21.4%
0KF3
US$0.19
Palatin Technologies
7D
0%
1Y
-85.9%
OPTI
UK£0.10
OptiBiotix Health
7D
-8.9%
1Y
-61.7%
FARN
UK£2.10
Faron Pharmaceuticals Oy
7D
9.1%
1Y
15.1%
SBTX
UK£0.16
SkinBioTherapeutics
7D
-3.0%
1Y
19.3%
CIZ
UK£0.014
Cizzle Biotechnology Holdings
7D
-9.7%
1Y
-17.6%